CGIX Analyst Day: Company and Portfolio Updates
Posted on: Thursday, October 9th, 2014
Cancer Genetics Inc. September 2014 Company and Portfolio Update
CEO Panna Sharma provides introductory remarks.
Dr. Gianrico Farrugia, Director of the Center for Individualized Medicine, Mayo Clinic, provides updates on OncoSpire, CGI’s joint venture with the Mayo Clinic.
Jane Houldsworth, Ph.D., VP of Research and Development discusses the CGI Hematological Portfolio.
Dr. Howard McLeod, Medical Director of the Miffitt Cancer Center discusses integrating pharmacogenomics into oncology.
Anna Marie Samulis, Field Product Manager for FHACT discusses FHACT, CGI’s proprietary test for cervical cancer screening.
Banumathy Gowrishankar, Ph.D., principal research scientist at CGI discusses the CGI Kidney Cancer Portfolio.